Determination of specific cardiac biomarkers (CBs) during the diagnosis and management
of adverse cardiovascular events such as acute myocardial infarction (AMI) has become …

Cardiac troponins (cTn) are currently the standard of care for the diagnosis of acute coronary
syndromes (ACS) in patients presenting to the emergency department (ED) with chest pain …

Background Heart-type fatty acid binding protein (H-FABP) has been proposed as an early
biomarker of myocardial infarction (MI). The authors aimed to undertake a systematic review …

The assessment of chest pain patients presenting to the emergency area (EA) is still a
clinical challenge, as the majority of patients are not diagnosed with acute coronary …

Objective (s): Scutellarin (Scu) is the main effective constituent of Erigeron breviscapus
which has anti-oxidant, anti-apoptotic, anti-inflammatory and other therapeutic properties …

BACKGROUND Patients with chest pain comprise a large proportion of emergency
presentations and place a major burden on healthcare resources. Therefore, efforts to safely …

Heart type fatty acid binding protein (HFABP) as an early marker of cardiac injury holds a
promising future with studies indicating surpassing performance as compared to myoglobin …

BACKGROUND: Measurement of high-sensitive cardiac troponin (hs-cTn) has facilitated the
early diagnostic assessment of chest pain patients. However, the information obtained from …

Introduction: Acute coronary syndrome (ACS) refers to a constellation of clinical symptoms
caused by acute myocardial ischemia. Cardiovascular diseases (CVDs) are major and …

Objective To examine the diagnostic accuracy of novel biomarkers of myocardial injury and
troponin assays for diagnosis of myocardial infarction. Methods 850 patients randomised to …